Inventor · disambiguated record
Yinfa Yan
Also filed as: YAN YINFA
11 granted patents·7 pending applications·144 citations·filing 2004–2022
89Inventor score
Top patents by PatentIndex Score
18 records- 0194US7259165B2Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Aug 21, 2007·72 cites·12 claims
- 0293US7576087B2Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Aug 18, 2009·29 cites·15 claims
- 0391US7417047B2Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulationWYETH CORP·Filed 2006·Granted Aug 26, 2008·19 cites·12 claims
- 0483US7482349B2Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretaseWYETH CORP·Filed 2005·Granted Jan 27, 2009·8 cites·18 claims
- 0580US7238696B2Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Jul 3, 2007·12 cites·14 claims
- 0678US11512055B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Nov 29, 2022·1 cites·2 claims
- 0775US10144737B2Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Dec 4, 2018·3 cites·12 claims
- 0870US12187684B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Jan 7, 2025·0 cites·18 claims
- 0963US2009253711A1Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2009·Application pending·0 cites
- 1062US7705030B2Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulationWYETH LLC·Filed 2008·Granted Apr 27, 2010·0 cites·18 claims
- 1160US7560470B2Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Jul 14, 2009·0 cites·9 claims
- 1258US7700602B2Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretaseWYETH LLC·Filed 2008·Granted Apr 20, 2010·0 cites·18 claims
- 1350US2022009910A1Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1450US2022169645A1Compounds as bruton tyrosine kinase inhibitors, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1548US2010168106A1Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase ModulationWYETH LLC·Filed 2010·Application pending·0 cites
- 1648US2008076801A1Indolylalkylpyridin-2-amines for the inhibition of beta-secretaseWYETH CORP·Filed 2007·Application pending·0 cites
- 1745US2007191431A12-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
- 1844US2007027199A1Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yinfa Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →